Elevance Health insider trading
Health Care · Strong buyingShare price and insider trades
Valuation, profit and volume
Summary
Over the past 12 months, 3 Elevance Health insiders reported open-market purchases totaling $2.2M, while 4 insiders reported sales totaling $1.7M. 0 of 5 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 50 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jul 17SEC | Gail BoudreauxCEO, President | Buy | 2,045 | $368.25 | $753K | +7.1% | — |
| Jul 17SEC | Ramiro G PeruDirector | Buy | 1,000 | $366.05 | $366K | +7.8% | — |
| Jul 17SEC | Gail BoudreauxCEO, President | Buy | 680 | $366.41 | $249K | +7.7% | — |
| Jun 15SEC | Ronald W PenczekCao & Controller | Sell | 369 | $403.16 | $149K | -2.1% | — |
| Jun 12SEC | Robert L Dixon Jr.Director | Sell | 151 | $401.77 | $61K | -1.8% | — |
| May 20SEC | Ronald W PenczekCao & Controller | Sell | 1,531 | $403.13 | $617K | -2.1% | — |
| Mar 23SEC | Amy W SchulmanDirector | Sell | 26 | $287.50 | $7K | +37.2% | — |
| Mar 9SEC | Charles Morgan Kendrick Jr.President | Sell | 3,196 | $284.92 | $911K | +38.5% | — |
| Mar 6SEC | Steven H CollisDirector | Buy | 3,000 | $289.84 | $870K | +36.1% | — |
Insiders at Elevance Health
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Gail BoudreauxCEO, President | $1.0M | — | Jul 17, 2026 | — |
| Steven H CollisDirector | $870K | — | May 15, 2026 | — |
| Ramiro G PeruDirector | $366K | — | Jul 17, 2026 | — |
| Charles Morgan Kendrick Jr.President | — | $911K | Mar 9, 2026 | — |
| Ronald W PenczekCao & Controller | — | $766K | Jun 15, 2026 | — |
| Robert L Dixon Jr.Director | — | $61K | Jun 12, 2026 | — |
| Amy W SchulmanDirector | — | $7K | May 15, 2026 | — |
| Erin M WesslingGeneral Counsel | — | — | Sep 4, 2026 | — |
| Ryan R CraigEvp & Chief Hr Officer | — | — | Sep 4, 2026 | — |
| Lewis Hay IIIDirector | — | — | May 15, 2026 | — |
| Ryan M. SchneiderDirector | — | — | May 15, 2026 | — |
| Susan D. DevoreDirector | — | — | May 15, 2026 | — |
| Deanna D Strable-soethoutDirector | — | — | May 15, 2026 | — |
| Antonio F NeriDirector | — | — | May 15, 2026 | — |
| Bahija JallalDirector | — | — | May 15, 2026 | — |
| Felicia F NorwoodEvp &Chief Health Benefits Ofr | — | — | Mar 4, 2026 | — |
| Peter D HaytaianEvp & Pres Carelon & Carelonrx | — | — | Mar 4, 2026 | — |
| Mark KayeCFO | — | — | Mar 4, 2026 | — |
| Ratnakar LavuEvp & Chief Digital Info Ofr | — | — | Mar 4, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about ELV insiders
Are Elevance Health insiders buying ELV stock?
In the past 12 months, 3 insiders reported open-market purchases of ELV worth $2.2M. The latest was CEO, President Gail Boudreaux bought $753K of ELV at $368.25 — largest purchase by this insider in our records.
Are Elevance Health insiders selling ELV stock?
4 insiders reported sales worth $1.7M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.